Samsung Biologics Competitors and Similar CompaniesClear all
Samsung Biologics's competitors and similar companies include Pharmaron, Catalent and PPD.
 Samsung Biologics Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization. |  Pharmaron Pharmaron Beijing (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. | |
Founding Date | Founding Date 2011 | Founding Date 2004 | Founding Date 2007 | Founding Date 1985 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Incheon, KR HQ Boston, US Ridgefield Park, US South San Francisco, US | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | |
Employees | Employees 4,770 | Employees 21,370 | Employees 12,6955% increase | Employees 24,5842% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) ₩4.6t (FY, 2025) | Revenue (est.) ¥13.9b (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) $4.7b (FY, 2020) |
Cost of goods | Cost of goods ₩1.4t (FY, 2025) | Cost of goods ¥9.2b (FY, 2025) | Cost of goods $3.4b (FY, 2024) | Cost of goods $1.7b (FY, 2020) |
Gross profit | Gross profit ₩3.1t (FY, 2025) | Gross profit ¥4.8b (FY, 2025) | Gross profit $953m (FY, 2024) | Gross profit $3b (FY, 2020) |
Net income | Net income ₩1.6t (FY, 2025) | Net income ¥1.6b (FY, 2025) | Net income ($1b) (FY, 2024) | Net income $160.6m (FY, 2020) |
Operating ⚠ | ||||
Backlog | Backlog N/A | Backlog N/A | Backlog $2.5b (FY, 2023) | Backlog $9.5b (Q3, 2021) |
Countries | Countries N/A | Countries N/A | Countries 80 (FY, 2023) | Countries 46 (FY, 2020) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 909m | Total funding raised $ 650m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Pharmaron
HQ
Beijing, CN
Employees
21,370
Pharmaron Beijing (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companyPPD
HQ
Wilmington, US
PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View company